Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis.

Area of Science:

• Immunology
• Complement System

Background:

• Common variable immunodeficiency (CVID) is characterized by antibody deficiencies, recurrent infections, and complications like bronchiectasis.
• The lectin complement pathway's role in CVID pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the involvement of the lectin complement pathway in CVID.
• To analyze serum levels of ficolin-2 and ficolin-3 and their association with CVID and its complications.
• To explore the genetic basis of ficolin deficiency in CVID by genotyping FCN2 and FCN3 single nucleotide polymorphisms (SNPs).

Main Methods:

• Serum samples from CVID patients and healthy controls were analyzed for ficolin-2 and ficolin-3 levels.
• Genotyping of single nucleotide polymorphisms (SNPs) in the FCN2 and FCN3 genes was performed.
• Statistical analyses were used to compare ficolin levels between groups and correlate with clinical manifestations.

Main Results:

• CVID patients exhibited significantly lower serum ficolin-2 levels compared to controls (P < 0.0001).
• The lowest ficolin-2 levels were observed in CVID patients with bronchiectasis (P = 0.0004) and autoimmunity (P = 0.04).
• While ficolin-3 levels were similar between CVID patients and controls, bronchiectasis patients showed lower levels (P = 0.0001).
• FCN2 gene SNP analysis confirmed known influences on ficolin-2 levels but did not reveal a genetic cause for deficiency in CVID.

Conclusions:

• Ficolin-2 deficiency is prevalent in CVID patients, particularly those with bronchiectasis.
• Ficolin-2 may serve as a potential biomarker for monitoring disease complications such as bronchiectasis in CVID patients.
• The underlying cause and clinical significance of ficolin-2 deficiency in CVID require further investigation.